InvestorsHub Logo
Followers 5
Posts 430
Boards Moderated 0
Alias Born 11/05/2013

Re: None

Thursday, 01/22/2015 10:46:59 AM

Thursday, January 22, 2015 10:46:59 AM

Post# of 92948
OCAT is_a Research Biotech, which have Certain Characteristics

Research Biotech Characteristics (some)
-No Revenue
-No Product Ready for the Market
-Share Price does not Represent Anything Real

To critique a research biotech for any of these
characteristics, is to not understand the very
purpose and nature of Research Biotech Companies.

A Research Biotech does not exist to generate Revenue.
A (start-up)Research Biotech doesn't have a marketable Product.
A Research Biotech's share price is completely Subjective.

Research Biotech Companies are a Brilliant Feature of
Modern American Capitalism. Thomas Edison invented it.

Now Positively, A Research Biotech solely exists
FOR RESEARCH, IT'S ONLY ABOUT THE RESEARCH !
Secondarily, the company must stay in business,
any way it can, TO CONTINUE ITS RESEARCH.
Share price is completely irrelevant, and subordinate
to these two things.

OCAT's Research is Proceeding Brilliantly.

Now OCAT is EVALUATING its Research.
This is done in the context of FDA Phased Trials.

Phase 1/2 is completed, PROVING the product is
safe to begin the next phase, pivotal phase 2B.
THIS IS MONUMENTALLY IMPORTANT.

OCATs RPE Cell Therapy is the FIRST Company to begin
the journey through the FDA process.

Therapeutic Cell Therapy is being forecast by GE to
grow to a Trillion Dollar Marketplace,heh!, over the next
decade through 2025. GE is in the top twenty market
cap companies in America, usually in the top ten.
And they sell high tech lab equipment, and provide
medical and patient services. They are major players
who are not 'guessing', they're adding up their order
books, and making enlightened forecasts.

I don't think anything can stop this company, unless
the management or the regulators intentionally bury it,
or intentionally drive it into a ditch.

We live in an age where common men live entire lives
without a meaningful wage raise. It wouldn't surprise
me if this never amounts to anything, share price-wise,
because lots of little people own this stock.
So, strongly against this company, we have conspiracy
and class-envy. And I don't 'know' that these things
aren't real.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.